These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 2096302)

  • 1. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1991; 3(2):225-37. PubMed ID: 1797154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    Thromb Res; 1991 Feb; 61(3):261-9. PubMed ID: 2028445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
    Ko FN; Yu SM; Chen IS; Ishii H; Chang YL; Huang TF; Teng CM
    Biochim Biophys Acta; 1993 Jan; 1175(2):225-31. PubMed ID: 8380343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
    Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the synthetic ether phospholipid KO-286011 on cells and components of rabbit blood.
    Hofmann B; Greiner J; Glusa E; Kertscher HP; Ostermann G
    Haemostasis; 1991; 21(2):77-84. PubMed ID: 1959801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
    Adnot S; Joseph D; Vargaftig BB
    Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig.
    Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P
    J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
    Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
    Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation.
    Heinroth-Hoffmann I; Hauser A; Mest HJ
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):181-2. PubMed ID: 2149184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K
    Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
    Schattner M; Parini A; Fouque F; Vargaftig BB; Touqui L
    Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkyl and alkoxycarbonyl derivatives of ginkgolide B: synthesis and biological evaluation of PAF inhibitory activity.
    Hu L; Chen Z; Xie Y; Jiang Y; Zhen H
    Bioorg Med Chem; 2000 Jun; 8(6):1515-21. PubMed ID: 10896127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of PAF-induced tPA release by KO-286011.
    Klöcking HP
    Ann N Y Acad Sci; 1992 Dec; 667():202-3. PubMed ID: 1309038
    [No Abstract]   [Full Text] [Related]  

  • 20. PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr.
    Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
    Eur J Pharmacol; 1992 Jul; 218(1):129-35. PubMed ID: 1327822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.